$EPZM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Epizyme, Inc.. Get notifications about new insider transactions in Epizyme, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10 2015 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 7,121 | 4,273 | 22,607 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.51 | 1,250 | 638 | 0 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.82 | 4,185 | 95,520 | 0 | 4.2 K to 0 (-100.00 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.90 | 4,186 | 95,879 | 4,185 | 8.4 K to 4.2 K (-50.01 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 7,121 | 4,273 | 8,371 | 1.3 K to 8.4 K (+569.68 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.51 | 1,250 | 638 | 1,250 | 0 to 1.3 K |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | M | 0.51 | 60,000 | 30,600 | 507,223 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 23.64 | 15,142 | 358,031 | 0 | 15.1 K to 0 (-100.00 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 23.07 | 44,858 | 1,035,049 | 15,142 | 60 K to 15.1 K (-74.76 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Buy | M | 0.51 | 60,000 | 30,600 | 60,000 | 0 to 60 K |
| May 06 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 16.36 | 400 | 6,542 | 1,000 | 600 to 1,000 (+66.67 %) |
| May 06 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 16.36 | 400 | 6,542 | 1,000 | 600 to 1,000 (+66.67 %) |
| Feb 17 2015 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Option Exercise | A | 21.58 | 35,778 | 772,089 | 35,778 | |
| Feb 17 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | A | 21.58 | 65,052 | 1,403,822 | 65,052 | |
| Feb 17 2015 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | A | 21.58 | 97,579 | 2,105,755 | 97,579 | |
| Feb 11 2015 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | A | 0.00 | 37,313 | 0 | 37,313 | |
| Feb 11 2015 | EPZM | Epizyme, Inc. | Singer Andrew E. | EVP & CFO | Option Exercise | A | 18.49 | 104,169 | 1,926,085 | 104,169 | |
| Dec 18 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 17.63 | 200 | 3,526 | 600 | 400 to 600 (+50.00 %) |
| Dec 18 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 17.63 | 200 | 3,526 | 600 | 400 to 600 (+50.00 %) |
| Dec 12 2014 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 20.73 | 17,666 | 366,216 | 17,666 | |
| Dec 04 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 21.16 | 400 | 8,465 | 400 | 0 to 400 |
| Dec 04 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 21.16 | 400 | 8,465 | 400 | 0 to 400 |
| Dec 04 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Buy | P | 21.19 | 200 | 4,238 | 200 | 0 to 200 |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 20,000 | 43,800 | 16,396 | |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.68 | 20,000 | 453,636 | 0 | 20 K to 0 (-100.00 %) |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 20,000 | 43,800 | 20,000 | 0 to 20 K |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Option Exercise | M | 2.19 | 868 | 1,901 | 21,702 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Sell | S | 26.44 | 868 | 22,950 | 13,073 | 13.9 K to 13.1 K (-6.23 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Buy | M | 2.19 | 868 | 1,901 | 13,941 | 13.1 K to 13.9 K (+6.64 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 13,414 | 29,377 | 36,396 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 6,586 | 3,952 | 29,728 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.10 | 3,700 | 96,566 | 0 | 3.7 K to 0 (-100.00 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 25.33 | 16,300 | 412,934 | 3,700 | 20 K to 3.7 K (-81.50 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 13,414 | 29,377 | 20,000 | 6.6 K to 20 K (+203.67 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 6,586 | 3,952 | 6,586 | 0 to 6.6 K |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 567,223 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 26.44 | 400 | 10,577 | 0 | 400 to 0 (-100.00 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 25.64 | 5,506 | 141,154 | 400 | 5.9 K to 400 (-93.23 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 24.77 | 24,094 | 596,893 | 5,906 | 30 K to 5.9 K (-80.31 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Oct 27 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Option Exercise | M | 3.54 | 535 | 1,894 | 18,210 | |
| Oct 27 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Sell | S | 30.00 | 535 | 16,050 | 13,073 | 13.6 K to 13.1 K (-3.93 %) |
| Oct 27 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Buy | M | 3.54 | 535 | 1,894 | 13,608 | 13.1 K to 13.6 K (+4.09 %) |
| Oct 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 276,500 | |
| Oct 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 23.38 | 2,000 | 46,760 | 429 | 2.4 K to 429 (-82.34 %) |
| Oct 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,429 | 429 to 2.4 K (+466.20 %) |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 36,314 | |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 27.74 | 1,000 | 27,740 | 0 | 1,000 to 0 (-100.00 %) |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.86 | 19,000 | 510,291 | 1,000 | 20 K to 1,000 (-95.00 %) |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 20,000 | 0 to 20 K |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Option Exercise | M | 2.19 | 868 | 1,901 | 22,570 | |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Sell | S | 27.06 | 868 | 23,488 | 13,073 | 13.9 K to 13.1 K (-6.23 %) |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Garbacz Stephen | Principal Accountin ... | Buy | M | 2.19 | 868 | 1,901 | 13,941 | 13.1 K to 13.9 K (+6.64 %) |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 597,223 | |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 27.06 | 500 | 13,530 | 0 | 500 to 0 (-100.00 %) |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Sell | S | 26.26 | 29,500 | 774,770 | 500 | 30 K to 500 (-98.33 %) |
| Oct 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | President & CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 56,314 | |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 25.55 | 20,000 | 510,990 | 0 | 20 K to 0 (-100.00 %) |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 20,000 | 0 to 20 K |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 44,000 | 22,440 | 149,459 | |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 44,000 | 22,440 | 138,000 | 94 K to 138 K (+46.81 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 278,500 | |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 28.67 | 2,000 | 57,340 | 429 | 2.4 K to 429 (-82.34 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,429 | 429 to 2.4 K (+466.20 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Option Exercise | A | 28.20 | 150,000 | 4,230,000 | 150,000 | |
| Sep 05 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 4,000 | 140,560 | 2,825,396 | 2.8 M to 2.8 M (-0.14 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.60 | 36,000 | 21,600 | 34,819 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 6,000 | 21,240 | 188,833 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 33.89 | 5,972 | 202,392 | 94,000 | 100 K to 94 K (-5.97 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 33.37 | 24,028 | 801,771 | 99,972 | 124 K to 100 K (-19.38 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.60 | 36,000 | 21,600 | 124,000 | 88 K to 124 K (+40.91 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 6,000 | 21,240 | 88,000 | 82 K to 88 K (+7.32 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 627,223 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 33.85 | 6,967 | 235,833 | 0 | 7 K to 0 (-100.00 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 33.35 | 23,033 | 768,068 | 6,967 | 30 K to 7 K (-76.78 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Aug 28 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 3,740 | 131,420 | 2,825,396 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 196,260 | 6,896,380 | 2,829,136 | 3 M to 2.8 M (-6.49 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.14 | 3,740 | 131,420 | 2,825,396 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.14 | 196,260 | 6,896,380 | 2,829,136 | 3 M to 2.8 M (-6.49 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 36.40 | 17 | 619 | 2,825,396 | 2.8 M to 2.8 M (0.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 36.40 | 883 | 32,144 | 2,825,413 | 2.8 M to 2.8 M (-0.03 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.13 | 3,723 | 130,801 | 2,826,296 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.13 | 195,377 | 6,864,239 | 2,830,019 | 3 M to 2.8 M (-6.46 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 32.46 | 2,394 | 77,707 | 3,025,396 | 3 M to 3 M (-0.08 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 32.46 | 125,606 | 4,077,058 | 3,027,790 | 3.2 M to 3 M (-3.98 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 33.04 | 723 | 23,884 | 3,153,396 | 3.2 M to 3.2 M (-0.02 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 33.04 | 37,943 | 1,253,455 | 3,154,119 | 3.2 M to 3.2 M (-1.19 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 36.40 | 17 | 619 | 2,825,396 | 2.8 M to 2.8 M (0.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 36.40 | 883 | 32,144 | 2,825,413 | 2.8 M to 2.8 M (-0.03 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.13 | 3,723 | 130,801 | 2,826,296 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.13 | 195,377 | 6,864,239 | 2,830,019 | 3 M to 2.8 M (-6.46 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 32.46 | 2,394 | 77,707 | 3,025,396 | 3 M to 3 M (-0.08 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 32.46 | 125,606 | 4,077,058 | 3,027,790 | 3.2 M to 3 M (-3.98 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 33.04 | 723 | 23,884 | 3,153,396 | 3.2 M to 3.2 M (-0.02 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 33.04 | 37,943 | 1,253,455 | 3,154,119 | 3.2 M to 3.2 M (-1.19 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.40 | 439 | 14,662 | 0 | -439 to 0 (-100.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.45 | 24 | 803 | 0 | -24 to 0 (-100.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.45 | 24 | 803 | 0 | -24 to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 280,500 | |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 38.60 | 2,000 | 77,200 | 0 | 2 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,000 | 0 to 2 K |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,326 | 48,422 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,199 | 150,852 | 1,326 | 5.5 K to 1.3 K (-76.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,274 | 46,523 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,031 | 144,816 | 1,274 | 5.3 K to 1.3 K (-75.98 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 35.93 | 325 | 11,676 | 0 | 325 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 325 | 0 | 325 | 0 to 325 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 35.67 | 325 | 11,593 | 0 | 325 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 325 | 0 | 325 | 0 to 325 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 374 | 0 | 374 | 0 to 374 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 374 | 0 | 374 | 0 to 374 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 37.03 | 559 | 20,699 | 0 | 559 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 559 | 0 | 559 | 0 to 559 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.70 | 195 | 7,156 | 0 | 195 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 195 | 0 | 195 | 0 to 195 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.72 | 455 | 16,708 | 0 | 455 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 455 | 0 | 455 | 0 to 455 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |